224 related articles for article (PubMed ID: 29554104)
21. The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members.
Mattii M; Ayala F; Balato N; Filotico R; Lembo S; Schiattarella M; Patruno C; Marone G; Balato A
Exp Dermatol; 2013 Dec; 22(12):813-9. PubMed ID: 24164463
[TBL] [Abstract][Full Text] [Related]
22. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
[TBL] [Abstract][Full Text] [Related]
23. IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation.
Wang X; Sun J; Hu J
PLoS One; 2015; 10(12):e0145498. PubMed ID: 26691862
[TBL] [Abstract][Full Text] [Related]
24. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
[TBL] [Abstract][Full Text] [Related]
25. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.
Yen LJ; Chen YC; Wang KC; Shih MC; Li CL; Yu SJ; Lu LY
Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):128-137. PubMed ID: 38059657
[TBL] [Abstract][Full Text] [Related]
26. An alternative pathway of imiquimod-induced psoriasis-like skin inflammation in the absence of interleukin-17 receptor a signaling.
El Malki K; Karbach SH; Huppert J; Zayoud M; Reissig S; Schüler R; Nikolaev A; Karram K; Münzel T; Kuhlmann CR; Luhmann HJ; von Stebut E; Wörtge S; Kurschus FC; Waisman A
J Invest Dermatol; 2013 Feb; 133(2):441-51. PubMed ID: 22951726
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Sun J; Dou W; Zhao Y; Hu J
Immunopharmacol Immunotoxicol; 2014 Feb; 36(1):17-24. PubMed ID: 24286371
[TBL] [Abstract][Full Text] [Related]
28. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
Milora KA; Fu H; Dubaz O; Jensen LE
J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
[TBL] [Abstract][Full Text] [Related]
29. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
Bai S; Zhang Z; Hou S; Liu X
Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
[TBL] [Abstract][Full Text] [Related]
30. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
[TBL] [Abstract][Full Text] [Related]
31. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
32. Involvement of high mobility group box-1 in imiquimod-induced psoriasis-like mice model.
Chen T; Fu LX; Guo ZP; Yin B; Cao N; Qin S
J Dermatol; 2017 May; 44(5):573-581. PubMed ID: 27943400
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis.
Chen Y; Yan H; Song Z; Chen F; Wang H; Niu J; Shi X; Zhang D; Zhang N; Zhai Z; Zhong B; Cheng L; Qian T; Hao F
PLoS One; 2015; 10(6):e0127957. PubMed ID: 26046540
[TBL] [Abstract][Full Text] [Related]
34. Lipocalin-2 exacerbates psoriasiform skin inflammation by augmenting T-helper 17 response.
Hau CS; Kanda N; Tada Y; Shibata S; Uozaki H; Fukusato T; Sato S; Watanabe S
J Dermatol; 2016 Jul; 43(7):785-94. PubMed ID: 26702876
[TBL] [Abstract][Full Text] [Related]
35. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory and Immunomodulatory Effects of Tripterygium wilfordii Multiglycoside in Mouse Models of Psoriasis Keratinocytes.
Zhang S; Li HJ; Yang CM; Liu L; Sun XY; Wang J; Chen ST; Lu Y; Hu MQ; Yan G; Zhou YQ; Miao X; Li X; Li B
Chin J Integr Med; 2024 Mar; 30(3):222-229. PubMed ID: 37597119
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod Treatment Causes Systemic Disease in Mice Resembling Generalized Pustular Psoriasis in an IL-1 and IL-36 Dependent Manner.
Alvarez P; Jensen LE
Mediators Inflamm; 2016; 2016():6756138. PubMed ID: 28057979
[TBL] [Abstract][Full Text] [Related]
39. Paeoniflorin suppresses inflammatory response in imiquimod-induced psoriasis-like mice and peripheral blood mononuclear cells (PBMCs) from psoriasis patients.
Chen T; Fu LX; Zhang LW; Yin B; Zhou PM; Cao N; Lu YH
Can J Physiol Pharmacol; 2016 Aug; 94(8):888-94. PubMed ID: 27348512
[TBL] [Abstract][Full Text] [Related]
40. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
